Hepatic cirrhosis caused by low-dose oral amiodarone therapy

Am J Med Sci. 2005 Nov;330(5):257-61. doi: 10.1097/00000441-200511000-00012.

Abstract

A 63-year-old man presented with ascites after therapy with amiodarone, 200 mg orally once per day for 22.5 months. A liver biopsy showed grade 3 chronic hepatitis and micronodular cirrhosis. The presence of striking microvesicular steatosis on light microscopy and lysosomal inclusion bodies on electron microscopy suggested amiodarone hepatotoxicity. This is the first reported case of amiodarone-induced hepatic cirrhosis associated with chronic treatment with 200 mg orally once per day for less than 2 years.

Publication types

  • Case Reports

MeSH terms

  • Amiodarone / adverse effects*
  • Amiodarone / therapeutic use
  • Anti-Arrhythmia Agents / adverse effects*
  • Anti-Arrhythmia Agents / therapeutic use
  • Dose-Response Relationship, Drug
  • Humans
  • Liver / drug effects*
  • Liver / pathology
  • Liver Cirrhosis / chemically induced*
  • Liver Cirrhosis / pathology
  • Male
  • Middle Aged

Substances

  • Anti-Arrhythmia Agents
  • Amiodarone